Article Text

Download PDFPDF

Other themes
P1-476 An assessment of the concentration-related prognostic value of cardiac troponin I in 1285 patients following acute coronary syndrome
  1. C P Gale1,2,
  2. E Metcalfe1,
  3. A D Simms1,3,
  4. R West1,
  5. C Morrell3,
  6. T Munyombwe1,
  7. W Harrison1,
  8. P D Batin4,
  9. A S Hall3,
  10. J H Barth1
  1. 1Centre for Epidemiology and Biostatistics, University of Leeds, Leeds, UK
  2. 2Department of Cardiology, York Teaching Hospital NHS Foundation Trust, York, UK
  3. 3Yorkshire Heart Centre, Leeds Teaching Hospitals NHS Trust, Leeds, UK
  4. 4Department of Cardiology, Mid-Yorkshire Hospitals NHS Trust, Wakefield, UK
  5. 5Department of Biochemistry, Leeds Teaching Hospitals NHS Trust, Leeds, UK


Introduction The British Cardiac Society, in 2004, redefined myocardial infarction by troponin concentration: cTnI ≤0.06 μg/l (unstable angina), cTnI >0.06 μg/l to <0.5 μg/l (myocardial necrosis), and cTnI≥0.5 μg/l (myocardial infarction). We investigated the effects of this classification on all cause mortality.

Methods Survival analysis of 1285 patients from the EMMACE-2 registry.

Results 528 deaths (6.6 year all cause mortality =41.1%). Survival was greatest in the cTnI ≤0.06 μg/l subgroup at 30 days (p=0.005), 6 months (p=0.015), 1 year (p=0.002) and at 6.6 years (p=0.045). After adjustment there was no statistically significant difference in survival between cTnI>0.06 and <0.5 μg/l and cTnI≥0.5 μg/l subgroups. Increased mortality (HR, 95% CI) was associated with ages 70 to 80 years (2.58, 1.17 to 3.91) and >80 years (3.30, 3.50 to 5.06), peripheral vascular disease (1.50, 1.16 to 1.94), heart failure (1.36, 1.05 to 1.83), diabetes (1.68, 1.36 to 2.07), severe LV dysfunction (1.50, 1.00 to 2.21) and creatinine per 10 μmol/l (1.65, 1.02 to 1.08), whereas ages 50 to 60 years (0.55, 0.32 to 0.96), β blockers (0.53, 0.44 to 0.64), aspirin (0.80 0.65 to 0.99), ACE inhibitors (0.67, 0.56 to 0.80), statins (0.73, 0.59 to 0.90) and revascularisation (0.33, 0.12 to 0.92) lowered the risk of death.

Conclusion Quantitative evaluation of cTnI concentration in ACS patients with a cTnI>0.06 μg/l is associated with no added prognostic information. However, the dichotomisation of patients by cTnI status (“positive” and “negative”) continues to facilitate ACS risk stratification.

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.